MRNA · Categories · Upgrades
MRNA - Analyst upgrades
Moderna Inc. (MRNA) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for MRNA
- Moderna upgraded by HSBC Securities with a new price targetHSBC Securities upgraded Moderna from Hold to Buy and set a new price target of $58.00
- Moderna upgraded by HSBC Securities with a new price targetHSBC Securities upgraded Moderna from Reduce to Hold and set a new price target of $82.00
- Moderna upgraded by Deutsche Bank with a new price targetDeutsche Bank upgraded Moderna from Sell to Hold and set a new price target of $80.00 from $85.00 previously
- Moderna upgraded by Oppenheimer with a new price targetOppenheimer upgraded Moderna from Perform to Outperform and set a new price target of $142.00
- Moderna upgraded by HSBC Securities with a new price targetHSBC Securities upgraded Moderna from Reduce to Hold and set a new price target of $69.00 from $89.00 previously
- Moderna upgraded by UBS with a new price targetUBS upgraded Moderna from Neutral to Buy and set a new price target of $191.00 from $221.00 previously
- Moderna upgraded by TD Cowen with a new price targetTD Cowen upgraded Moderna from Market Perform to Outperform and set a new price target of $180.00 from $150.00 previously
- Moderna upgraded by Jefferies with a new price targetJefferies upgraded Moderna from Hold to Buy and set a new price target of $275.00 from $170.00 previously
- Moderna upgraded by SVB Leerink with a new price targetSVB Leerink upgraded Moderna from Underperform to Mkt Perform and set a new price target of $101.00 from $174.00 previously
- Moderna upgraded by Deutsche Bank with a new price targetDeutsche Bank upgraded Moderna from Hold to Buy and set a new price target of $165.00
- Moderna upgraded by RedburnRedburn upgraded Moderna from Sell to Neutral
- Moderna upgraded by Deutsche Bank with a new price targetDeutsche Bank upgraded Moderna from Sell to Hold and set a new price target of $175.00
- Moderna upgraded by B of A Securities with a new price targetB of A Securities upgraded Moderna from Underperform to Neutral and set a new price target of $180.00 from $135.00 previously
- Moderna upgraded by Piper Sandler with a new price targetPiper Sandler upgraded Moderna from Neutral to Overweight and set a new price target of $445.00
- Moderna upgraded by Piper SandlerPiper Sandler upgraded Moderna from Neutral to Overweight